Risk Factors for Aseptic Meningitis in Herpes Zoster Patients
Overview
Authors
Affiliations
Background: Herpes zoster (HZ) is caused by reactivation of latent varicella-zoster virus (VZV) infection. HZ-associated aseptic meningitis, a rare complication of HZ, can require hospitalization and a long treatment period.
Objective: A retrospective study was performed to identify potential factors associated with HZ-associated aseptic meningitis development.
Methods: We included all outpatients and patients admitted in the neurology and dermatology departments of a single tertiary center, who were diagnosed with HZ for two years. Among 818 patients, 578 patients were eligible for analysis.
Results: The demographics and potential risk factors were compared between the uncomplicated HZ group (n=554) and aseptic meningitis group (n=24). Among the potential factors, the dermatological distribution of skin rash and gender showed statistically significantly different between the two groups. Patients with craniocervical distribution of HZ accounted for 87.5% (n=21) of the aseptic meningitis group and 54.3% (n=301) of the uncomplicated HZ group (=0.043). The aseptic meningitis group had more men (66.7%, n=16) than the uncomplicated HZ group (42.8%, n=237, =0.033). Patients with craniocervical distribution had an odds ratio (OR) of 5.884 (=0.001) for developing aseptic meningitis when compared with the other dermatome involvements. Additional logistic regression analysis resulted in a fading between gender difference (=0.050) and craniocervical involvement having an OR of 5.667 for aseptic meningitis (=0.006).
Conclusion: In HZ patients, skin rash with craniocervical distribution and male gender were associated with a higher risk of aseptic meningitis.
Wang J, Yuan Y, Liu H, Zhang Y, Yan Y Med Sci Monit. 2024; 30:e945835.
PMID: 39733239 PMC: 11694422. DOI: 10.12659/MSM.945835.
The Role of Varicella Zoster Virus (VZV) in Central Nervous System Infectious Syndromes.
Yakovenko V, Ciobotaro P, Bardenstein R, Zusev M, Zimhony O Can J Infect Dis Med Microbiol. 2024; 2024:6664417.
PMID: 39624438 PMC: 11611393. DOI: 10.1155/cjid/6664417.
Lewandowski D, Toczylowski K, Kowalska M, Krasnodebska M, Krupienko I, Nartowicz K Vaccines (Basel). 2024; 12(9).
PMID: 39340116 PMC: 11435507. DOI: 10.3390/vaccines12091086.
Chen J, Abrahamson P, Ke Y, Ong C, Parikh R, Shantakumar S Hum Vaccin Immunother. 2024; 20(1):2344983.
PMID: 38767209 PMC: 11110703. DOI: 10.1080/21645515.2024.2344983.
Yan Y, Yuan Y, Wang J, Zhang Y, Liu H, Zhang Z Am J Transl Res. 2022; 14(1):491-500.
PMID: 35173869 PMC: 8829630.